This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S, a pivotal entity within the Roche Group, is headquartered in Denmark (DK) and plays a significant role in the biotechnology and pharmaceutical industry. Founded in 2010, the centre focuses on pioneering research and development in the fields of RNA-targeted therapies and personalised medicine, contributing to Roche's commitment to innovative healthcare solutions. With a strong emphasis on developing unique therapeutic approaches, Roche Innovation Center Copenhagen has made notable strides in advancing RNA-based treatments. The centre's collaborative environment fosters innovation, positioning it as a leader in the biopharmaceutical landscape. Its achievements in drug discovery and development underscore Roche's dedication to improving patient outcomes globally, solidifying its reputation as a key player in the industry.
DitchCarbon Score
How does Roche Innovation Center Copenhagen A/S's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche Innovation Center Copenhagen A/S's score of 81 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche Innovation Center Copenhagen A/S, headquartered in Denmark (DK), currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The organisation is a current subsidiary of Roche Holding AG, which may influence its climate commitments and performance metrics. While there are no documented reduction targets or specific climate pledges from Roche Innovation Center Copenhagen A/S, it is important to note that any climate initiatives or targets may be inherited from its parent company, Roche Holding AG. This includes potential commitments to the Science Based Targets initiative (SBTi) and other sustainability frameworks, although specific details on these initiatives are not provided. As a part of the broader Roche corporate family, Roche Innovation Center Copenhagen A/S is likely aligned with industry-standard climate strategies, focusing on reducing carbon emissions and enhancing sustainability practices. However, without specific emissions data or reduction targets, the current climate impact and commitments of Roche Innovation Center Copenhagen A/S remain unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 249,350,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 114,452,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 6,402,719,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Roche Innovation Center Copenhagen A/S is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
